$IPH $IPHA

Innate Pharma is hosting an event for investors and analysts dedicated to its Antibody-Drug Conjugate strategy, and particularly Nectin-4, the target of its lead ADC program, IPH4502

📅 February 5, 2025
📍 New York
🟠 From 10:00 am to 12:00 pm edt

www.innate-pharma.com/media/all-pr...